Navigation Links
CutisPharma Announces Strategic Collaboration with Rite Aid Corporation
Date:7/30/2008

Rite Aid to make available FIRST(R) Unit-of-Use prescription compounding

kits to its stores nationwide through Rite Aid distribution centers

WOBURN, Mass., July 30 /PRNewswire/ -- CutisPharma, Inc., an industry leader in developing products for prescription compounding, announced a partnership with Rite Aid Corporation (NYSE: RAD) that will make its innovative FIRST(R) Unit-of-Use Prescription Compounding Kits available for the approximately 27,000 pharmacists and pharmacy technicians at approximately 5,000 Rite Aid stores nationwide. Rite Aid will carry CutisPharma's FIRST(R) Unit-of-Use Prescription Compounding Kits nationwide in all its distribution centers, assuring constant availability. FIRST(R) products will allow Rite Aid the ability to offer compounding service to their customers and, for pharmacies already providing the service, increase the efficiency of their compounding offerings.

FIRST(R) Unit-of-Use Prescription-Compounding Kits are designed to provide an easy and time- saving solution for pharmacies. The pre-measured, pre- weighed components enable pharmacists to dispense the prescribed dosage accurately every time. A single NDC number assigned for the entire kit for each product greatly simplifies the third-party reimbursement process and reduces audit related adjustments. In addition, use of these kits facilitates compliance with the United States Pharmacopeia (USP) Chapter < 795 >.

"Our FIRST(R) Unit-of-Use compounding kits are user-friendly, save compounding time (by over 70%), and can be compounded by a Rite Aid pharmacist while the patient waits, increasing Rite Aid customer satisfaction and eliminating the need for an extra trip to the pharmacy," said Dr. Indu Muni, Chairman & CEO of CutisPharma.

Rite Aid Pharmacies will work with CutisPharma in notifying local physicians about the availability of compounding services at neighborhood Rite Aid stores using FIRST(R) kits.

It is estimated that approximately 30 million retail and hospital outpatient compounded prescriptions are prepared annually in the United States. About 1% of all prescriptions are compounded; and the U.S. market alone for compounding, at the consumer level, represents an estimated $1 billion annually.

CutisPharma currently has nine proprietary prescription compounding kits in the market:
-- five strengths of progesterone suppository compounding kits;

-- two testosterone kits;

-- one hydrocortisone kit;

-- one Magic Mouthwash kit.

The company plans to introduce several more compounding kits in late 2008 and 2009.

About Rite Aid Corporation

Rite Aid Corporation is one of the nation's leading drugstore chains with approximately 5,000 stores in 31 states and the District of Columbia with fiscal 2008 annual sales of more than $24.3 billion. Information about Rite Aid, including corporate background and press releases, is available through the company's website at http://www.riteaid.com.

About CutisPharma, Inc.

CutisPharma, Inc., based in Woburn, MA, is a privately held, specialty pharmaceutical company focusing on developing and commercializing value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 8 million currently compounded prescriptions, by offering FIRST(R) Unit-of-Use Prescription Compounding Kits. A U.S. patent has been issued to the Company and additional patents are pending.

Contact:

James Nagle

V.P. Business Development

CutisPharma, Inc.

781-935-8141 x120

For more information please visit our website at http://www.cutispharma.com


'/>"/>
SOURCE CutisPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
2. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
3. BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy
4. Align Technology Announces Second Quarter Fiscal 2008 Results
5. Monogram Announces 2008 Second Quarter Financial Results
6. Webcast Alert: Medial Saude S/A Announces Second Quarter 2008 Earnings Conference Call Webcast
7. The Quantum Group Announces Exclusive Screening of New PWeR(TM) System
8. Burgess Announces Expanded Software Partnership With Health Net
9. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
10. Fast Radios Announces Publication of Two Way Radio Guide for Commercial Customers
11. Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , ... May 27, 2016 , ... W.S. Badger ... announced today that it has been recognized as one of the best small businesses ... was named as one of nine small businesses providing progressive benefits to new parents ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... with Mediaplanet to help educate the many who are unaware of the plight ... to aphasia will run within the “Stroke Awareness” campaign. , The link between ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... in the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation ... providing proof of successfully certified products, services and staff. , Validation Center is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, ... members and suppliers for its inaugural Member Conference at the Paris Hotel in ... elevating the operational health of America’s healthcare providers. , The conference was highlighted ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia ... negative impact on long-term patient survival, reports a team of UPMC researchers in ... week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... England , May 25, 2016 ... company employing the precision of circulating tumour DNA ... today announces the appointment of Professor Clive ... provide medical leadership across the clinical development programme, ... Inivata,s products help deliver significant improvements in clinical ...
Breaking Medicine Technology: